Newsroom
13-04-21 - Event
Wyss Zurich Founding Co-Director Roland Siegwart in a talk about Robotics and the future of manufacturing at HANNOVER MESSE Digital Edition 2021. Register and watch the live streaming today at 16:00-16.25 (CEST)!
read more12-04-21 - Media Coverage
Swiss science is world-class – but the movers and shakers are often hardly known. In this feature Swiss magazine BILANZ presents Pierre-Alain Clavien and the Wyss Zurich project Liver4Life causing worldwide sensation by developing a machine for regenerating human livers outside of the body.
read more31-03-21 - Press Release
The Wyss Zurich project Phire wins Venture Kick's first stage of financial and entrepreneurial support for its novel bispecific antibody for the treatment of Acute Myeloid Leukemia.
read more29-03-21 - Media Coverage
The software of Wyss Zurich project Seervision operates cameras as if it were a human and facilitates video productions. The start-up has its roots at ETH Zurich, where students once developed a clunky prototype for recording lectures.
read more26-03-21 - Media Coverage
The NZZ covers the Wyss Zurich project and its Spin-off hemotune and their approach to cure COVID19 patients with magnets and artificial proteins. Read the full article (in German)
read more10-03-21 - Media Coverage
In 2021, you should know how emerging startups will impact the advanced robotics industry. Discover 5 hand-picked, global startups that were founded in 2019 & 2020 and develop innovative solutions for your sector!
read more19-02-21 - Media Coverage
Congratulations to the Wyss Zurich project Voliro for making it on the list of the "10 super promising Switzerland-based startups to watch in 2021".
read more16-02-21 - Media Coverage
Eleven million people die each year as a result of sepsis. With its revolutionary idea, hemotune around founder Lukas Langenegger wants to solve this problem. This makes the company onto the Forbes list 30 "Spin-offs To Watch 2021" in the DACH region. Read the full article (in German)
read more03-02-21 - Event
Deana Mohr, CEO and Co-Founder of MUVON Therapeutics, and Project Leader of our Wyss Zurich associate project MUS.I.C., will pitch on the De Vigier Selection Day, where 60 young companies will enter the race for up to five coveted W.A. de Vigier Awards. The pitches can be followed on February 4, 2021, as of 9 am, via a public live stream on the foundation's website. Wyss Zurich wishes good luck!
read more28-01-21 - Spotlight
Learn about the Wyss Zurich outreach project PATHOS in Open/Ended #12 Aparna Rao: On Art & Behaviour with Robotics
read more